Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
ASBPCompany Name
ASPIRE BIOPHARMA HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQASPIRE BIOPHARMA HOLDINGS INC - Price to Free Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ASBP - P/FCF Historical data
| Date | Free Cash Flow | Market Capitalization | Price to Free Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ -304.72K | $ 19.76M | 0 |
| 3/31/2025 | $ 243.28K | $ 11.79M | 48.45 |
| 12/31/2024 | $ -265.19K | $ 24.94M | 0 |
| 9/30/2024 | $ -2.98M | $ 90.02M | 0 |
| 6/30/2024 | $ -3.13M | $ 87.2M | 0 |
| 3/31/2024 | $ -2.73M | $ 88.29M | 0 |
| 12/31/2023 | $ -653.11K | $ 99.35M | 0 |
| 9/30/2023 | $ -532.85K | $ 98.09M | 0 |
| 6/30/2023 | $ -454.55K | $ 94.86M | 0 |
| 3/31/2023 | $ -302.97K | $ 378.42M | 0 |
Key Performance Insights, Last 5 Years
- ASPIRE BIOPHARMA HOLDINGS INC's latest trailing twelve months (TTM) P/FCF stands at 0.
- Over the past 5 years, ASPIRE BIOPHARMA HOLDINGS INC's average P/FCF has been 48.45.
- The median P/FCF for ASPIRE BIOPHARMA HOLDINGS INC during this period was 48.45
- ASPIRE BIOPHARMA HOLDINGS INC reached its highest P/FCF over the past 5 years at 48.45.
- The lowest P/FCF recorded by ASPIRE BIOPHARMA HOLDINGS INC in the same timeframe 48.45
Similar metrics to P/FCF:
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
Definition of Price to Free Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].Market Cap / FCF
(=) P/FCF P/FCF for ASPIRE BIOPHARMA HOLDINGS INC is calculated as follows: Market Cap [ $ 0 ] / FCF [ $ -238.6K ]
(=) P/FCF [ 0 ] ASBP - Price to Free Cash Flow, Last 5 years
48.45
Minimum
Mar 31, 2025
48.45
Maximum
Mar 31, 2025
48.45
Average
48.45
Median
P/FCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/FCF for companies in the Total Stock Market. The average P/FCF of the companies is 18.31 with a standard deviation of 12.93.
The following table provides additional summary stats:
P/FCF in the Market:
| filtered constituents | 2.23K |
|---|---|
| min | 0.06 |
| max | 60.45 |
| average | 18.31 |
| median | 14.73 |
| std | 12.93 |